MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

Midcontinent Independent System Operator, or MISO, is collaborating with Microsoft (MSFT) for grid modernization.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

8 old programming languages developers won’t quit Newer languages might soak up all the glory, but these die-hard languages have their place. Here are eight languages developers still use daily, and ...